NCT06238375Not yet recruiting
Protocol for The Lipid Registry of Africa
Protocol for The Lipid Registry of Africa (LIPRA)
Source: ClinicalTrials.gov · Last updated 2 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Lipid Registry of Africa (LIPRA) aims to understand why some individuals in Africa experience heart issues at a younger age than others. The study investigates factors causing heart problems in younger adults, particularly acute coronary syndrome (ACS). Acute coronary syndrome (ACS) includes various heart conditions like unstable angina and heart attacks. Researchers from multiple African countries collaborate to gather information from hospitals across the region. They focus on patients under 55 years (men) or 65 years (women) with heart issues. Additionally, the study wants to compare different groups-men and women, urban and rural residents-to see if there are specific differences in how heart problems develop among them.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 24 Jan 2024
- Start date
- 30 Apr 2024
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- European Atherosclerosis Society
- Diseases
- Coronary artery disease
- NCT number
- NCT06238375
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 30 Apr 2024 to the primary completion date, 30 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients not admitted to designated cardiac facilities in Africa.
- Diagnosed cases not meeting the specified criteria for Acute Coronary Syndrome (ACS) subtypes (STEMI, NSTEMI/UAP) based on symptoms, electrocardiogram (ECG), and biomarker levels.
Age
- Individuals outside the defined age range for premature Acute Coronary Syndrome (ACS) diagnosis.
Who the study is looking for
- Individuals diagnosed with premature Acute Coronary Syndrome (ACS) within the defined age range (≤55 years in men and ≤65 years in women).
- Patients admitted to designated cardiac facilities in Africa (Urban and rural).
- Diagnosed cases of ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction/unstable angina pectoris (NSTEMI/UAP) based on predetermined criteria including symptoms, electrocardiogram (ECG) alterations, and biomarker levels.
- Patients exhibiting an increase (above the 95th percentile) or decrease in serum troponin levels as per admission standards.
Age in the registry: - to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.